1. Home
  2. VIR vs SLDP Comparison

VIR vs SLDP Comparison

Compare VIR & SLDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • SLDP
  • Stock Information
  • Founded
  • VIR 2016
  • SLDP 2011
  • Country
  • VIR United States
  • SLDP United States
  • Employees
  • VIR N/A
  • SLDP N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • SLDP Electrical Products
  • Sector
  • VIR Health Care
  • SLDP Energy
  • Exchange
  • VIR Nasdaq
  • SLDP Nasdaq
  • Market Cap
  • VIR 706.4M
  • SLDP 645.4M
  • IPO Year
  • VIR 2019
  • SLDP N/A
  • Fundamental
  • Price
  • VIR $5.63
  • SLDP $6.06
  • Analyst Decision
  • VIR Strong Buy
  • SLDP Strong Buy
  • Analyst Count
  • VIR 11
  • SLDP 1
  • Target Price
  • VIR $25.73
  • SLDP $4.00
  • AVG Volume (30 Days)
  • VIR 1.1M
  • SLDP 14.2M
  • Earning Date
  • VIR 10-30-2025
  • SLDP 11-06-2025
  • Dividend Yield
  • VIR N/A
  • SLDP N/A
  • EPS Growth
  • VIR N/A
  • SLDP N/A
  • EPS
  • VIR N/A
  • SLDP N/A
  • Revenue
  • VIR $19,000,000.00
  • SLDP $22,667,000.00
  • Revenue This Year
  • VIR N/A
  • SLDP $27.38
  • Revenue Next Year
  • VIR $15.25
  • SLDP $37.97
  • P/E Ratio
  • VIR N/A
  • SLDP N/A
  • Revenue Growth
  • VIR N/A
  • SLDP 14.83
  • 52 Week Low
  • VIR $4.16
  • SLDP $0.68
  • 52 Week High
  • VIR $14.45
  • SLDP $6.44
  • Technical
  • Relative Strength Index (RSI)
  • VIR 59.22
  • SLDP 75.25
  • Support Level
  • VIR $5.36
  • SLDP $3.71
  • Resistance Level
  • VIR $6.00
  • SLDP $3.96
  • Average True Range (ATR)
  • VIR 0.28
  • SLDP 0.52
  • MACD
  • VIR 0.03
  • SLDP 0.23
  • Stochastic Oscillator
  • VIR 65.62
  • SLDP 95.40

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About SLDP Solid Power Inc.

Solid Power Inc is engaged in solid-state battery technology and manufacturing processes. Its core technology is a sulfide-based solid electrolyte material, which replaces the liquid or gel electrolyte used in traditional lithium-ion battery cells. Its commercialization plan is to manufacture and sell electrolytes to Tier 1 battery manufacturers and automotive original equipment manufacturers (OEMs) that choose to produce its battery cells.

Share on Social Networks: